These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7522307)

  • 1. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis.
    Hernandez D; Concepcion MT; Lorenzo V; Martinez ME; Rodriguez A; De Bonis E; Gonzalez-Posada JM; Felsenfeld AJ; Rodriguez M; Torres A
    Nephrol Dial Transplant; 1994; 9(5):517-23. PubMed ID: 7522307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.
    Coen G; Ballanti P; Bonucci E; Calabria S; Costantini S; Ferrannini M; Giustini M; Giordano R; Nicolai G; Manni M; Sardella D; Taggi F
    Nephron; 2002 May; 91(1):103-11. PubMed ID: 12021526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of adynamic bone disease by lowering of dialysate calcium.
    Haris A; Sherrard DJ; Hercz G
    Kidney Int; 2006 Sep; 70(5):931-7. PubMed ID: 16837920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function.
    Hercz G; Pei Y; Greenwood C; Manuel A; Saiphoo C; Goodman WG; Segre GV; Fenton S; Sherrard DJ
    Kidney Int; 1993 Oct; 44(4):860-6. PubMed ID: 8258962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal osteodystrophy in predialysis patients without stainable bone aluminum. A cross-sectional bone-histomorphometric study.
    Dahl E; Nordal KP; Attramadal A; Halse J; Flatmark A
    Acta Med Scand; 1988; 224(2):157-64. PubMed ID: 2458677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The early effects of aluminium deposition and dialysis on bone in chronic renal failure: a cross-sectional bone-histomorphometric study.
    Dahl E; Nordal KP; Halse J; Flatmark A
    Nephrol Dial Transplant; 1990; 5(6):449-56. PubMed ID: 2122323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal osteodystrophy in diabetic patients.
    Pei Y; Hercz G; Greenwood C; Segre G; Manuel A; Saiphoo C; Fenton S; Sherrard D
    Kidney Int; 1993 Jul; 44(1):159-64. PubMed ID: 8355457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
    Bervoets AR; Spasovski GB; Behets GJ; Dams G; Polenakovic MH; Zafirovska K; Van Hoof VO; De Broe ME; D'Haese PC
    Am J Kidney Dis; 2003 May; 41(5):997-1007. PubMed ID: 12722034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for renal osteodystrophy: a multivariant analysis.
    Pei Y; Hercz G; Greenwood C; Segre G; Manuel A; Saiphoo C; Fenton S; Sherrard D
    J Bone Miner Res; 1995 Jan; 10(1):149-56. PubMed ID: 7747622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathormone secretion in peritoneal dialysis patients with adynamic bone disease.
    Carmen Sánchez M; Auxiliadora Bajo M; Selgas R; Mate A; Millán I; Eugenia Martínez M; López-Barea F
    Am J Kidney Dis; 2000 Nov; 36(5):953-61. PubMed ID: 11054351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adynamic bone and chronic renal failure: an overview.
    Cannata Andía JB
    Am J Med Sci; 2000 Aug; 320(2):81-4. PubMed ID: 10981480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
    Sebert JL; Fournier A; Leflon P; Fohrer P; de Frémont JF; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
    Nephron; 1986; 42(1):34-40. PubMed ID: 3941748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.
    Mathias R; Salusky I; Harman W; Paredes A; Emans J; Segre G; Goodman W
    J Am Soc Nephrol; 1993 Jun; 3(12):1938-46. PubMed ID: 8338926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study.
    Coen G; Mazzaferro S; Ballanti P; Sardella D; Chicca S; Manni M; Bonucci E; Taggi F
    Nephrol Dial Transplant; 1996 May; 11(5):813-9. PubMed ID: 8671900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone biopsy results and serum bone turnover parameters in uremic children.
    Ziólkowska H; Pańiczyk-Tomaszewska M; Debiński A; Polowiec Z; Sawicki A; Sieniawska M
    Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
    Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
    Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.